ICLR
Price
$153.40
Change
+$2.58 (+1.71%)
Updated
Jul 3, 10:43 AM (EDT)
Capitalization
27.35B
20 days until earnings call
WILLF
Price
$41.75
Change
+$0.55 (+1.33%)
Updated
Jun 27 closing price
Capitalization
8.95B
Interact to see
Advertisement

ICLR vs WILLF

Header iconICLR vs WILLF Comparison
Open Charts ICLR vs WILLFBanner chart's image
ICON
Price$153.40
Change+$2.58 (+1.71%)
Volume$1.3K
Capitalization27.35B
Demant AS
Price$41.75
Change+$0.55 (+1.33%)
Volume$100
Capitalization8.95B
ICLR vs WILLF Comparison Chart in %
Loading...
ICLR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WILLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ICLR vs. WILLF commentary
Jul 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ICLR is a Buy and WILLF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 03, 2025
Stock price -- (ICLR: $150.82 vs. WILLF: $41.75)
Brand notoriety: ICLR and WILLF are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ICLR: 43% vs. WILLF: 43%
Market capitalization -- ICLR: $27.35B vs. WILLF: $8.95B
ICLR [@Medical Specialties] is valued at $27.35B. WILLF’s [@Medical Specialties] market capitalization is $8.95B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.65B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ICLR’s FA Score shows that 0 FA rating(s) are green whileWILLF’s FA Score has 0 green FA rating(s).

  • ICLR’s FA Score: 0 green, 5 red.
  • WILLF’s FA Score: 0 green, 5 red.
According to our system of comparison, WILLF is a better buy in the long-term than ICLR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ICLR’s TA Score shows that 4 TA indicator(s) are bullish while WILLF’s TA Score has 2 bullish TA indicator(s).

  • ICLR’s TA Score: 4 bullish, 4 bearish.
  • WILLF’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, ICLR is a better buy in the short-term than WILLF.

Price Growth

ICLR (@Medical Specialties) experienced а +3.37% price change this week, while WILLF (@Medical Specialties) price change was +1.33% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +2.12%. For the same industry, the average monthly price growth was +2.45%, and the average quarterly price growth was -0.37%.

Reported Earning Dates

ICLR is expected to report earnings on Jul 23, 2025.

Industries' Descriptions

@Medical Specialties (+2.12% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ICLR($27.4B) has a higher market cap than WILLF($8.95B). ICLR has higher P/E ratio than WILLF: ICLR (44.81) vs WILLF (25.84). WILLF YTD gains are higher at: 12.716 vs. ICLR (-28.082). WILLF has higher annual earnings (EBITDA): 4.3B vs. ICLR (1.52B). WILLF has more cash in the bank: 1.13B vs. ICLR (380M). ICLR has less debt than WILLF: ICLR (3.94B) vs WILLF (15.1B). WILLF has higher revenues than ICLR: WILLF (19.7B) vs ICLR (8.12B).
ICLRWILLFICLR / WILLF
Capitalization27.4B8.95B306%
EBITDA1.52B4.3B35%
Gain YTD-28.08212.716-221%
P/E Ratio44.8125.84173%
Revenue8.12B19.7B41%
Total Cash380M1.13B34%
Total Debt3.94B15.1B26%
FUNDAMENTALS RATINGS
ICLR vs WILLF: Fundamental Ratings
ICLR
WILLF
OUTLOOK RATING
1..100
2576
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
70
Overvalued
PROFIT vs RISK RATING
1..100
10066
SMR RATING
1..100
7698
PRICE GROWTH RATING
1..100
6348
P/E GROWTH RATING
1..100
9782
SEASONALITY SCORE
1..100
95n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ICLR's Valuation (69) in the Pharmaceuticals Other industry is in the same range as WILLF (70) in the null industry. This means that ICLR’s stock grew similarly to WILLF’s over the last 12 months.

WILLF's Profit vs Risk Rating (66) in the null industry is somewhat better than the same rating for ICLR (100) in the Pharmaceuticals Other industry. This means that WILLF’s stock grew somewhat faster than ICLR’s over the last 12 months.

ICLR's SMR Rating (76) in the Pharmaceuticals Other industry is in the same range as WILLF (98) in the null industry. This means that ICLR’s stock grew similarly to WILLF’s over the last 12 months.

WILLF's Price Growth Rating (48) in the null industry is in the same range as ICLR (63) in the Pharmaceuticals Other industry. This means that WILLF’s stock grew similarly to ICLR’s over the last 12 months.

WILLF's P/E Growth Rating (82) in the null industry is in the same range as ICLR (97) in the Pharmaceuticals Other industry. This means that WILLF’s stock grew similarly to ICLR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ICLRWILLF
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
43%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
66%
Bearish Trend 1 day ago
33%
Momentum
ODDS (%)
Bullish Trend 1 day ago
64%
Bearish Trend 1 day ago
38%
MACD
ODDS (%)
Bullish Trend 7 days ago
78%
Bearish Trend 1 day ago
29%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
66%
Bullish Trend 1 day ago
45%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
65%
Bullish Trend 1 day ago
46%
Advances
ODDS (%)
Bullish Trend 1 day ago
67%
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
63%
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
57%
Bullish Trend 1 day ago
51%
View a ticker or compare two or three
Interact to see
Advertisement
ICLR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WILLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FLSW38.230.19
+0.49%
Franklin FTSE Switzerland ETF
EFA89.500.26
+0.29%
iShares MSCI EAFE ETF
EDOW38.720.01
+0.03%
First Trust Dow 30 Equal Weight ETF
BSJP23.08N/A
N/A
Invesco BulletShares 2025 HY Corp Bd ETF
SMDD14.57-0.43
-2.88%
ProShares UltraPro Short MidCap400

ICLR and

Correlation & Price change

A.I.dvisor indicates that over the last year, ICLR has been closely correlated with IQV. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if ICLR jumps, then IQV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ICLR
1D Price
Change %
ICLR100%
+1.30%
IQV - ICLR
69%
Closely correlated
+1.25%
TMO - ICLR
55%
Loosely correlated
+1.49%
A - ICLR
53%
Loosely correlated
+0.17%
BRKR - ICLR
53%
Loosely correlated
+1.34%
DHR - ICLR
53%
Loosely correlated
+0.70%
More

WILLF and

Correlation & Price change

A.I.dvisor tells us that WILLF and MEDP have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that WILLF and MEDP's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WILLF
1D Price
Change %
WILLF100%
N/A
MEDP - WILLF
24%
Poorly correlated
+1.55%
CLPBY - WILLF
23%
Poorly correlated
+0.74%
VERO - WILLF
23%
Poorly correlated
+12.60%
ICLR - WILLF
20%
Poorly correlated
+1.30%
WILYY - WILLF
14%
Poorly correlated
N/A
More